September 9, 2024 – We received an R01 grant from NIGMS to develop a PEG alternative for protein delivery. We thank the support from NIH.

June 7, 2024 – Olivia and Amelia won the 1st place in COE Senior Design General Competition. Congratulations!

December 19, 2022 – Our review article titled “Cell delivery devices for cancer immunotherapy” has been accepted for publication in Journal of Controlled Release.

January 8, 2021 – Our research article titled “PEGylation Enables Subcutaneously Administered Nanoparticles to Induce Antigen-Specific Immune Tolerance” has been accepted for publication in Journal of Controlled Release. Congratulations Peter!

July 7, 2020 – Our review article titled “Engineering Long-Circulating Nanomaterial Delivery Systems” has been accepted for publication in Current Opinion in Biotechnology.

June 1, 2020 – Kevin passed his MS thesis defense and will join Merck to start his career in a few months. Congratulations! We wish Kevin a very successful career.

May 23, 2020 – In working with our collaborators, we have published a research article about inducing immune tolerance to reverse new-onset of type 1 diabetes in Advanced Materials !